Product Information
ALFUZOSIN HCL ER 10 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1074 per EA under NDC 69097084407. Its NADAC has been published 464 times since Oct 12, 2016.
FDA first approved this application on Jan 17, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Cipla USA Inc.NDC
69097084407
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
ALFUZOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090284FDA Approved
1/17/2012
TE Code
AB
On Market Since
6/30/2016
Pharmacological Classes
Price Statistics
The NADAC for ALFUZOSIN HCL ER 10 MG TABLET has been published 464 times since Oct 12, 2016, and over the history we have for it it has declined 42.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1074 per EA |
|---|---|
| All-time high | $0.1922 (Nov 16, 2016) |
| All-time low | $0.1034 (Jan 22, 2025) |
| 52-week high | $0.1078 |
| 52-week low | $0.1052 |
| Median price | $0.1323 |
| Average price | $0.1350 |
| Largest weekly change | +32.0% (Nov 22, 2023) |
| Weeks tracked | 464 |
| Tracking since | Oct 12, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-0.0%
3Y
-15.5%
5Y
-18.9%
All
-42.1%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALFUZOSIN HCL ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALFUZOSIN HCL ER 10 MG TABLET, manufactured by Cipla USA Inc., is $0.1074 per EA (NDC 69097084407), effective Feb 18, 2026.
How has the price of ALFUZOSIN HCL ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has declined 42.1%. It has been tracked across 464 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for ALFUZOSIN HCL ER 10 MG TABLET?
Since Oct 12, 2016, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has ranged from a low of $0.1034 (Jan 22, 2025) to a high of $0.1922 (Nov 16, 2016), with a median of $0.1323 per EA.
Are there cheaper alternatives to ALFUZOSIN HCL ER 10 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALFUZOSIN HCL ER 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ALFUZOSIN HCL ER 10 MG TABLET?
ALFUZOSIN HCL ER 10 MG TABLET (NDC 69097084407) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.